1Song BC, Suh DJ, Lee HC, et al. Hepatitis B e antigen seroconversion after lamivudine therapy is not durable in patients with chronic hepatitis B in Korea. Hepatology, 2000,32: 803-806.
2Leung NWY, Lai CL, Chang TT, et al. Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen serconversion rates: results after 3 years of therapy. Hepatology,2001,33:1527-1532.
3Lau GKK, Tsiang M, Hou JL, et al. Combination therapy with lamivudine and famciclovir for chronic hepatitis B-infected Chinese patients: A viral dynamics study. Hepatology, 2000,32: 394-399.
4Serfaty L, Thabut D, Zoulim F, et al. Sequential treatment with lamivudine and interferon monotherapies in patients with chronic hepatitis B not responding to interferon alone: results of a pilot study. Hepatology, 2001,34: 573-582.
5Shaw T, Locarnini S. Combination chemotherapy for hepatitis B virus:The final solution? Hepatology, 2000,32: 430-432.
